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ABSTRACT
The efficacy of whole parasite and vesicular fluid antigen extracts from Taenia solium and Taenia crassiceps cysticerci for immunodiagnosis 
of neurocysticercosis was evaluated using ELISA on cerebrospinal fluid samples. Anticysticercal IgG antibodies were assayed in cerebrospinal 
fluid samples from 23 patients with neurocysticercosis and 35 patients with other neurological disorders. The ELISA reaction for the whole 
Taenia solium cysticercal extract showed 91.3% sensitivity and 94.3% specificity, whereas the sensitivity and specificity of the ELISA for the 
whole Taenia crassiceps cysticercal extract were 87% and 94.3%, respectively. The ELISA reactions for vesicular fluid from Taenia solium or 
Taenia crassiceps showed 91.3% sensitivity and 97.1% specificity. Considering the results obtained from the four antigen preparations, vesicular 
fluid from Taenia solium and Taenia crassiceps cysticerci may be useful as a source of antigens for immunological reactions that are used for 
detecting specific antibodies in cerebrospinal fluid samples from patients with neurocysticercosis. 
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RESUMO
A eficácia de extratos antigênicos de parasitas totais e líquido vesicular de cisticercos de Taenia solium e Taenia crassiceps para o imunodiagnóstico 
da neurocisticercose foi avaliada por meio de reações de ELISA em amostras de líquido cefalorraquidiano. Anticorpos IgG anti-cisticercos 
foram pesquisados em amostras de líquido cefalorraquidiano de 23 pacientes com neurocisticercose e 35 pacientes com outras doenças 
neurológicas. A reação ELISA com o extrato bruto total de cisticercos de Taenia solium apresentou 91,3% de sensibilidade e 94,3% de 
especificidade, enquanto a sensibilidade e a especificidade da reação ELISA com o extrato total de cisticercos de Taenia crassiceps foram 87% 
e 94,3%, respectivamente. As reações ELISA com o líquido vesicular de Taenia solium ou Taenia crassiceps mostraram 91,3% de sensibilidade 
e 97,1% de especificidade. Considerando os resultados obtidos com as quatro preparações antigênicas, o liquido vesicular de cisticercos de 
Taenia solium e Taenia crassiceps pode ser útil como fonte de antígenos em reações imunológicas usadas para detectar anticorpos específicos 
em amostras de líquido cefalorraquidiano de pacientes com neurocisticercose.
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Neurocysticercosis is a severe disease caused by the presence 
of the encysted larval stage (cysticercus) of the tapeworm 
Taenia solium in the human central nervous system (CNS). It is 
recognized as a major public health problem in many developing 
countries and is an increasingly important emerging infection in 
some developed countries with a high influx of immigrants from 
endemic areas1 6 15 25.
The clinical diagnosis of neurocysticercosis is hindered 
by the great variety and non-specificity of the symptoms6 15 22. 
Neuroimaging techniques such as computed tomography (CT) 
and magnetic resonance imaging (MRI) have been recognized 
as the gold standard for diagnosing neurocysticercosis22. 
However, in many cases, these techniques may not provide a 
definitive diagnosis of neurocysticercosis, because the complex 
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pathological processes of this disease in the CNS often mimic other 
infectious or non-infectious diseases7 14. In addition, it is not easy 
to demonstrate the parasites in some areas of the CNS. CT, and 
even conventional MRI, may fail to detect cysticercal cysts in the 
cerebrospinal fluid spaces21. In addition to their high cost, these 
sophisticated procedures are rarely available in most endemic 
areas of developing countries. 
Detection of specific antibodies in cerebrospinal fluid (CSF) 
samples against T. solium cysticercal antigens using reliable 
techniques such as enzyme-linked immunosorbent assay (ELISA) 
has been considered to be an important tool for diagnosing 
neurocysticercosis, especially when neuroimaging techniques are 
unavailable or inconclusive5 14. Pigs presenting natural infection 
with T. solium larvae are generally difficult to obtain, and this 
has stimulated a search for alternative sources of antigens for 
immunodiagnosis of neurocysticercosis. The larval form of the 
related species Taenia crassiceps (ORF strain), which reproduces 
asexually by intraperitoneal passage through Balb/c mice, has 
been used as a source of antigens for detecting anticysticercal 
antibodies in immunological tests2 5 12 13 17.
There is no agreement about the best antigen preparation to 
use in ELISA for neurocysticercosis. Some authors have used crude 
extracts of whole T. solium or T. crassiceps cysticerci, whereas 
others have used crude extracts from particular components 
of the parasites (scolex, membrane or vesicular fluid), or even 
purified antigens12 15 22. In the present study, the performance of 
whole parasite and vesicular fluid extracts from T. solium and 
T. crassiceps cysticerci for immunodiagnosis of neurocysticercosis 
by ELISA in CSF samples was evaluated.
MATERIAL AND METHODS
Cerebrospinal fluid samples. A collection of 58 CSF 
samples was screened for the presence of cysticercus-specific IgG, 
by means of ELISA. The samples were obtained from 23 patients 
with neurocysticercosis and 35 patients with other neurological 
disorders (neurosyphilis [n=4], neurotoxoplasmosis [n=5], 
neurocryptococcosis [n=5], viral meningitis [n=10], multiple 
sclerosis [n=6] and chronic headache [n=5]). The patients with 
neurocysticercosis had CT and/or MRI results compatible with this 
disease, whereas the patients with other neurological disorders 
had no epidemiological and radiological evidence of infection by 
T. solium. All the patients were recruited at the University Hospital 
of the State University of Campinas (UNICAMP) (Campinas, São 
Paulo, Brazil). This study was approved by the Ethics Committee 
of the School of Medical Sciences, UNICAMP, in accordance with 
the resolutions of the Brazilian National Ethics Committee.
Cysticercal antigens. T. solium cysticerci were obtained from 
a heavily infected, freshly slaughtered pig. T. crassiceps larvae (ORF 
strain) were maintained by intraperitoneal inoculation of cysts into 
8 to 12-week-old female Balb/c mice. Intact T. solium and 
T. crassiceps cysticerci were washed extensively with sterile phosphate-
buffered 0.15M saline, at pH 7.2 (PBS) and aliquoted into plastic tubes 
to produce whole cysticercal antigens (TsoW and TcraW), or into Petri 
dishes to collect vesicular fluid antigens (TsoVF and TcraVF). 
The parasites in plastic tubes were resuspended in approximately 
three volumes of PBS containing 5mM phenylmethylsulfonyl 
fluoride (PMSF) and 0.0025mM leupeptin. The material was then 
homogenized in an ice-water bath using a Polytron homogenizer 
(Brinkmann Instruments, Inc., Westbury, NY, USA) equipped with 
a PT-20 ST probe (three 30 s pulses at speed 3, with 30 s intervals 
between pulses). The homogenate was then sonicated for 3 min 
(1 min sonications, with pauses of 1 min) in an ice-water bath 
using a Branson Sonicator (model SX-30) at a power setting of 
three with a 20% pulse duty cycle. Protease inhibitors (PMSF and 
leupeptin) were subsequently added to the sonicated material at 
the final concentrations described above and the suspension was 
then stirred gently for 2h at 4°C. Centrifugation of the homogenate 
at 15,000 xg for 60 min at 4°C resulted in a white floating layer 
followed by a clear supernatant and the pellet. The floating layer 
was removed with a Pasteur pipette, and the supernatant was 
collected and filtered through 0.45µm filters (Millex filters, 
Millipore Corporation, Bedford, MA, USA).
The parasites in Petri dishes were ruptured individually using 
two needles, and the vesicular fluid released was collected with a 
Pasteur pipette and transferred to centrifuge tubes. The fluid was 
then centrifuged at 10,000 xg for 30 min at 4°C and the supernatants 
were sonicated for 1 min (two 30 s sonications, with a 30 s interval 
between pulses) in an ice-water bath using a Branson Sonicator 
(model SX 30, Branson Ultrasonics, Danbury, CT, USA) at a power 
setting of three with a 20% pulse duty cycle. After sonication, PMSF 
and leupeptin were added to the vesicular fluid antigen to give final 
concentrations of 5mM and 0.0025mM, respectively. 
After determining the protein concentrations3, the antigen 
preparations were aliquoted and stored at –80°C until used. 
Human serum pools. A human serum pool positive for 
cysticercosis (CYSP) and a normal human serum (NHS) pool 
were prepared as previously described2. The CYSP was initially 
used to determine the optimum reagent concentrations for ELISA 
and, subsequently, as a standard in each ELISA plate. The NHS pool 
served as a negative control in ELISA.
ELISA. The assay was done as previously described23, with the 
following modifications: the cysticercal antigens were diluted to 
3µg of protein/ml in 0.1M carbonate-bicarbonate buffer, at pH 9.5, 
prior to sensitizing U-bottomed ELISA plates. The CSF samples and 
the CYSP were diluted to 1:2 and 1:100, respectively, in PBS-Tween 
containing 1% bovine serum albumin. Each CSF sample and the 
CYSP were tested in triplicate with the four antigen preparations 
in the same plate and the mean absorbance was determined. 
The final optical density (OD) for each CSF sample and the CYSP 
was determined by subtracting the mean OD of the three antigen 
controls in the corresponding plate. The results were expressed as 
an antibody index (AI) by dividing the final OD of the CSF sample 
by the final OD of the CYSP2. The cutoff value for ELISA was defined 
as the mean of the results obtained from the 35 CSF samples from 
patients with no epidemiological and radiological evidence of 
infection by T. solium plus two standard deviations.
The sensitivity, specificity and diagnostic accuracy for each 
assay were determined using the SAS System for Windows, version 
9.1.3 (SAS Institute Inc., Cary, NC, USA). 
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RESULTS
Twenty-three CSF samples from patients with neurocysticercosis 
and 35 CSF samples from patients with other neurological disorders 
were tested by ELISA using cysticercal antigen extracts from 
T. solium cysticerci (TsoW and TsoVF) and T. crassiceps cysticerci 
(TcraW and TcraVF). Table 1 summarizes the performances of the 
assays with the four cysticercal antigens. The TsoW-ELISA showed 
91.3% sensitivity and 94.3% specificity, whereas the sensitivity and 
specificity of the TcraW-ELISA were 87% and 94.3%, respectively. 
The TsoVF-ELISA and TcraVF-ELISA showed 91.3 sensitivity and 
97.1% specificity.
Table 1 - ELISA results for diagnosing neurocysticercosis using different 
cysticercal antigen preparations.
Antigen Sensitivity (%) Specificity (%) Accuracy (%)      
TsoW 91.3 94.3 93.1
TcraW 87.0 94.3 91.4
TsoVF 91.3 97.1 94.8
TcraVF 91.3 97.1 94.8
Tso: Taenia solium; Tcra: Taenia crassiceps; W: whole parasite; VF: vesicular fluid
In the group of 23 CSF samples from patients with 
neurocysticercosis, 19 were positive with TsoW-ELISA, TcraW-
ELISA, TsoVF-ELISA and TcraVF-ELISA, whereas one CSF sample 
was negative with the four antigen preparations. In the group of 35 
CSF samples from patients with other neurological disorders, one 
CSF sample from a patient with neurotoxoplasmosis was positive 
with TsoW-ELISA and TcraW-ELISA, whereas one CSF sample from 
a patient with neurocryptococcosis was positive with TsoW-ELISA, 
TcraW-ELISA, TsoVF-ELISA and TcraVF-ELISA. 
The highest diagnostic accuracy (A) values were obtained 
with TsoVF-ELISA and TcraVF-ELISA (A=94.8%).
DISCUSSION
The diagnosis of neurocysticercosis frequently depends on 
a combination of clinical, epidemiological, neuroimaging, and 
laboratory data. CT and MRI have been considered to be the most 
reliable tools for diagnosing neurocysticercosis6 11 22. However, 
among the many neuroimaging findings for neurocysticercosis, 
only the presence of cystic lesions showing the scolex has been 
considered pathognomonic11. Due to their high cost and restricted 
availability, these diagnostic procedures may be of limited use in 
developing countries with high rates of cysticercosis. Immunological 
tests have been widely applied for detecting anticysticercal antibodies 
in serum and CSF samples using different antigen preparations. In 
these studies, conducted mainly with immunoenzymatic tests, there 
is marked variation in the performances of cysticercal antigens, with 
sensitivities ranging from 47% to 100% and specificities ranging 
from 67% to 100%2 5 12 22 24.
Few reports have simultaneously compared the usefulness of 
different antigen preparations from T. solium or T. crassiceps 
cysticerci for immunodiagnosis of neurocysticercosis using 
quantitative immunoassays2 4 23. In the present report, the usefulness 
of whole parasite and vesicular fluid extracts from T. solium and 
T. crassiceps cysticerci for immunodiagnosis of neurocysticercosis 
was evaluated by quantitative ELISA on CSF samples. Our results 
showed that T. solium and T. crassiceps cysticercal antigens 
had similar efficiency, and the best performance was obtained 
with TsoVF-ELISA and TcraVF-ELISA (91.3% sensitivity; 97.1% 
specificity; A=94.8%).
Several authors have shown that immunological tests for 
neurocysticercosis are less likely to react in patients with a single 
cyst or calcified parasites than in those with multiple, noncalcified 
parasites6 11 12 15 22. In the present study, one CSF sample from a 
patient with neurocysticercosis gave negative results with the four 
antigens. This patient had neuroimaging results showing a single 
cyst with the scolex in the cerebral parenchyma.
The greatest difficulty the serological diagnosis of 
neurocysticercosis has been the cross-reactivity between 
cysticercal antigens and serum antibodies from patients with 
other infections, including echinococcosis, gnathostomiasis, 
strongyloidiasis, angiostrongyliasis, fascioliasis, ascariasis, 
toxocariasis and schistosomiasis9 10 18 19. Although lower cross-
reactivity has been documented when CSF samples are used, 
false-positive reactions for neurocysticercosis have been described 
in patients with neurotoxoplasmosis, neurotuberculosis, and 
neuroschistosomiasis8 20 23. However, it is important to stress 
that in most studies designed to evaluate the efficiency of antigen 
preparations for immunodiagnosis of neurocysticercosis, control 
CSF samples from patients with CNS infectious diseases or other 
parasitic infections have frequently not been tested. In the present 
study, cross-reactions with a CSF sample from a patient with 
neurocryptococcosis were detected with the four antigens. The 
patient’s medical history and the results of neuroimaging studies 
revealed no signs of neurocysticercosis. 
Significant variations are often seen in the ELISA results for 
neurocysticercosis. These variations are probably related to several 
factors, including the intrinsic properties of the diagnostic technique. 
The inclusion of a CYSP, which was tested with all four antigen 
preparations in every plate, and the expression of the results as an 
antibody index (AI = CSF sample OD/ CYSP OD) greatly reduced 
the variability in the reactivity of the ELISA. Production of a CYSP by 
an international institution and making it available for inclusion in 
immunological reactions such as ELISA could allow more reliable 
comparison between the results obtained by different laboratories.
Some studies have showed that ELISA standardized with 
vesicular fluid from T. solium or T. crassiceps cysticerci may 
be a potentially useful diagnostic tool for immunodiagnosis 
of neurocysticercosis2 5 16 18. Our results confirmed that this 
component of the parasites might be useful as a source of antigen 
in immunological reactions for detecting specific antibodies in 
patients with neurocysticercosis. For routine diagnostic purposes, 
sensitive and specific antigen preparations must be available 
in cost-effective amounts. Vesicular fluid can be obtained in 
sufficiently large quantities with relative ease, particularly when 
T. crassiceps cysticerci are available.
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